A behavioural and biochemical evaluation of Î±â‚‚-adrenoceptor antagonist fipamezole in experimental models of Parkinson's disease

A behavioural and biochemical evaluation of Î±â‚‚-adrenoceptor antagonist fipamezole in experimental models of Parkinson's disease

Bibliographic Details
Main Author:	Croft, Neil Ramsay
Published:	King's College London (University of London) 2006
Subjects:	616.833061
Online Access:	http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.429684

Similar Items

A behavioural and biochemical evaluation of the momoamine uptake inhibitor BTS 73 398 in the 6-hydroxydopamine lesioned rat model of Parkinson's disease
by: Lane, Emma Louise
Published: (2004)

Parkinson's disease : behavioural effects following extracellular deposition of non-beta amyloid component and pharmacological interventions
by: Elliott, Jennifer Jane
Published: (2004)

An evaluation of the potentially neuroprotective properties of cannabinoids in a cell culture model of Parkinson's disease
by: Zeissler, Marie-Louise
Published: (2013)

Nicotinamide : neuroprotection and neurodegeneration mechanisms in Parkinson's disease
by: Cartwright, Lindsay Sarah
Published: (2005)

The role of neopterin derivatives in the pathogenesis and treatment of Parkinson's disease
by: Noble, Stephen Paul
Published: (2002)

Group III metabotropic glutamate receptors as potential targets in the treatment of Parkinson's disease
by: Broadstock, Martin
Published: (2006)

The neuronal nicotinic acetylcholine receptor as a potential symptomatic and neuroprotective target in Parkinson's disease
by: Visanji, Naomi
Published: (2004)

Neuroprotective effects of metabotropic glutamate receptor ligands in a rodent 6-hydroxydopamine model of Parkinson's disease
by: Vernon, Anthony Christopher
Published: (2007)

The role of group II and III metabotropc glutamate receptors in the basal ganglia and their potential as a treatment target for Parkinson's disease
by: Messenger, Marcus John
Published: (2003)

Striatal and extra-striatal dopaminergic function in Parkinson's disease and the effect of dopamine agonist therapy on PD progression studies with 3D[Â¹â¸F]-dopa PET
by: Rakshi, James
Published: (2003)

Parkin protects against pathogenic mechanisms involved in cell death
by: Dowman, Julia Rebecca Louise
Published: (2005)

An investigation of the potential antiparkinsonian activity of combined dopamine D2 and serotonin 1A receptor agonists
by: Johnston, Louisa Clare
Published: (2004)

In vitro and in vivo investigations of the potential neuroprotective effects of propargylamines and dopamine receptor agonists
by: Wakselman, Shirley
Published: (2007)

Mechanisms of action of L-DOPA : a behavioural and biochemical study in experimental models of Parkinson's disease
by: Treseder, Sarah Anne
Published: (2001)

The electrophysiological and molecular effects of chronic β-adrenoceptor antagonist therapy on human atrium
by: Marshall, Gillian Elizabeth
Published: (2008)

Regulation of glucose uptake in skeletal muscle by Î²-adrenoceptor agonists and antagonists and interaction with peroxisome proliferator-activated receptors Î± and Î´
by: Ngala, Robert A.
Published: (2006)

The role of plasma protein binding in the biochemical pharmacology of spirolactones and beta-adrenoceptor antagonists
by: Lobo, P. J.
Published: (1986)

Beta adrenoceptor response in asthma
by: Greenacre, Judith Kathleen
Published: (1978)

Evaluation of monoamine reuptake inhibition in experimental models of Parkinson's disease
by: Hansard, Matthew James
Published: (2002)

Vascular B-adrenoceptors and pressor response to B-adrenoceptor antagonists
by: Abdelrahman, Aly Mohamed Omar
Published: (2011)

A Clinical and Biochemical Study of L-Dopa in the Treatment of Parkinson's Disease
by: Morris, J. G. L.
Published: (1976)

Pathological gambling and other addictive behaviours in Parkinson's disease
by: Djamshidian-Tehrani, A.
Published: (2013)

Predicting cognitive impairment in Parkinson's disease using neurophysiology and biochemical parameters as biomarkers
by: Yarnall, Alison Jane
Published: (2013)

Analysis of pathology and ex vivo biochemical outcomes following administration of an anti-VLA-4 antagonist in models of experimental allergic encephalomyelitis
by: Rundle, Jon Leigh
Published: (2010)

A behavioural evaluation of the potential of nNOS inhibitors to control dyskinesia in animal models of Parkinson's disease
by: Hirsch, Tamara
Published: (2012)

The in-vivo impact of genetic variation in the beta-1 adrenoceptor
by: Stanton, Tony
Published: (2005)

beta-adrenoceptor subtypes involved in myocardial preconditioning and postconditioning
by: Penson, Peter Edward
Published: (2009)

Biochemical characterisation of the Parkinson's disease-associated kinase PINK1 : insights from the insect world
by: Woodroof, Helen I.
Published: (2014)

Ischaemia/reperfusion injury and preconditioning in the human myocardium : the role of alpha 1 adrenoceptors and disease states
by: Loubani, Mahmoud
Published: (2005)

Studies on the properties of some β adrenoceptor antagonists
by: Street, James A.
Published: (1979)

Adrenoceptor blocking effects of Labetalol in man and their implications in the treatment of hypertension
by: Richards, D. A.
Published: (1977)

The feasibility of using brief cognitive behavioural therapy for depression associated with Parkinson's disease
by: Cole, Kristina
Published: (2003)

Behavioural analysis of 6-hydroxydopamine rodent models of Parkinson's disease
by: Heuer, Andreas
Published: (2012)

Oscillations in the basal ganglia in Parkinson's disease patients and their influence on the cerebral cortex and behavioural performance
by: Fogelson, Noa
Published: (2005)

Genetic variation of Î±-adrenoceptors in relation to the aetiology and treatment of psychotic disorders
by: Clark, Daniel Andrew
Published: (2005)

Characterisation and regulation of vascular and lower urinary tract Î±â‚-adrenoceptors
by: Bagot, Kathryn Lisa
Published: (2005)

Mechanical unloading and β2-adrenoceptor stimulation for the treatment of heart failure
by: Soppa, Gopal Krishna Ranganathan
Published: (2009)

Biochemical studies of beta-adrenoceptor heterogeneity
by: Dickinson, Kenneth Ernest John
Published: (1982)

Structure-activity studies on alphaâ†2-adrenoceptor antagonists
by: O'Neill, Hugh Charles
Published: (1989)

Staff responses to challenging behaviour : an evaluation of behaviour analytic concepts and intervention strategies
by: Bathurst, Neil
Published: (1997)